Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 31, 2026
Reporting period
Not applicable
Filed with the SEC
Apr 2, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references dividend reinvestment
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001222676-26-000004
Filed / recorded
Apr 2, 2026, 8:15 PM UTC
Added to OQRO
Oct 2, 2026, 12:29 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
ZIMMER BIOMET HOLDINGS, INC.
Issuer CIK
1136869
Ticker
ZBH
Reporting person
Robert Hagemann
Relationship
Director
Security
Phantom Stock Units
Table
Derivative (Table II)
Transaction date
Mar 31, 2026
Transaction code
A
Shares / units
308.711
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
31,982.841
Ownership form
Direct
Amendment
No
Footnotes from the filing
The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
The Conversion or Exercise Price of Derivative Security is 1-for-1.
Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
Includes 87.178 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.